NCT02753127 2023-11-15
CanStem303C
Sumitomo Pharma America, Inc.
Phase 3 Completed
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.